Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16275-16281
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16275
Table 1 Clinical characteristics of the 32 patients with ruptured hepatocellular carcinoma n (%)
VariableTotal (n = 32)
Age
Mean (range), yr53 (39-71)
Gender (male/female)25/7
Etiology
HBV/HCV/alcohol/others25 (78.1)/2 (6.3)/2 (6.3)/3 (9.4)
Child-Pugh classification
A/B/C3 (9.4)/12 (37.5)/10 (31.3)
Extra-liver sites of metastatic disease4 (12.5)
Tumor size (cm)8.3 (2.9-25.5)
Tumor number
Single/multiple8 (25.0)/24 (75.0)
Within Milan criteria3 (9.4)
BCLC stage
0/A/B/C/D0 (0.0)/3 (9.4)/11 (34.4)/ 12 (37.5)/6 (18.8)
Alpha-fetoprotein (ng/mL)
mean (range)864 (6-54000)
Treatment Resection/TAE(TACE)22 (68.8)/10 (31.2)
Sorafenib12 (37.5)